Physician profile
Macey E Mcaleer
NPI 1669666053
$5,112.38
in general payments reported to CMS, 2019-2025
14 companies · $756 in 2025
The $756 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2021: $148 · 2022: $240 · 2023: $2,585 · 2024: $1,111 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,748 · Travel and Lodging: $1,536 · Entertainment: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,747.72 |
| Travel and Lodging | $1,536.38 |
| Entertainment | $167.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,779.24 | 2023 | Clarus, Cirrus Hd-Oct, Humphrey Field Analyzer (Hfa3) |
| Coopervision INC. | $851.82 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Alcon Vision LLC | $610.52 | 2019-2025 | Precision 1, Total30, Acrysof Iq Vivity |
| Johnson & Johnson Vision Care, INC. | $380.67 | 2023-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $276.29 | 2024-2025 | Infuse Multifocal, Infuse |
| Dompe US, INC. | $229.75 | 2024-2025 | Oxervate |
| Lkc Technologies, INC. | $227.55 | 2023-2024 | |
| Optos, INC. | $190.47 | 2022-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Amgen INC. | $146.55 | 2024 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2021 | |
| Horizon Therapeutics Plc | $121.12 | 2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $120.00 | 2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $30.29 | 2019 | |
| Sight Sciences, INC. | $23.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macey Mcaleer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.